针对血液癌症的CRISPR-Cas系统的进展
Bernice Monchusi1, Phumuzile Dube1, Mutsa Monica Takundwa1
1Synthetic Nanobiotechnology and Biomachines, Synthetic Biology and Precision Medicine Centre, Future production Chemicals Cluster, Council for Scientific and Industrial Research, Pretoria, South Africa.
Progress in molecular biology and translational science
|September 12, 2024
概括
通过CRISPR-Cas基因编辑,通过准遗传特征,提供个性化的血液癌症治疗. 虽然对CAR-T等疗法充满希望,但在广泛临床使用方面,安全性和监管方面的挑战仍然存在.
科学领域:
- 生物技术是生物技术.
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 通过基因定制,CRISPR-Cas系统正在彻底改变精密医学.
- 使用CRISPR技术在血液癌症中准特定基因正在取得进展,其中一些正在进入临床试验.
- CRISPR-Cas显示出增强血液癌症免疫治疗反应的潜力,包括CAR-T细胞治疗.
研究的目的:
- 审查CRISPR-Cas技术在彻底改变血液癌症治疗中的变革潜力.
- 突出CRISPR-Cas系统在针对血液癌症的个性化医学中的应用.
- 讨论CRISPR-Cas技术在治疗血液癌症方面的进展和挑战.
主要方法:
- 本综述综合了关于CRISPR-Cas在血液癌症治疗中的应用的当前研究.
- 它检查了CRISPR技术在血液恶性瘤中用于基因向的使用.
- 该审查考虑了CRISPR-Cas与CAR-T细胞疗法等免疫疗法的整合.
主要成果:
- 克里斯普尔-卡斯技术使得基于个体遗传资料的个性化治疗成为可能.
- 基于CRISPR的疗法正在进行临床试验,这些疗法针对血液癌症中的特定基因.
- 在血液癌症治疗中,CRISPR-Cas增强了免疫疗法 (如CAR-T细胞疗法) 的疗效.
结论:
- 克里斯普尔-卡斯技术对彻底改变血液癌症治疗具有重大前景.
- 需要进一步的研究和开发,以克服与体内应用相关的挑战.
- 解决安全,伦理和监管方面的问题对于广泛采用CRISPR-Cas治疗血液癌症至关重要.
更多相关视频
12:04Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
3.5K
07:01Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
Published on: May 2, 2025
103
相关概念视频
01:59CRISPR
49.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.8K
02:53CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
02:31Homologous Recombination
50.3K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.3K